Teva Gains Another $2.48 Billion For Selling The Last Of Its Women???s Health Portfolio Post author:Sam Post published:September 17, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Bay Area Acerta Pharma Falsified Early Data on a Cancer Compound, Now in Clinical Trials October 5, 2017 Sanofi's Bad End-of-the-Year Continues With Axing of Its C. Diff Drug December 3, 2017 2 Small-Cap Biotechs Bestie Celgene is Cutting Back On December 27, 2017
Bay Area Acerta Pharma Falsified Early Data on a Cancer Compound, Now in Clinical Trials October 5, 2017